The United Arab Emirates has become the second country in the world to approve the innovative drug 'Empagliflozin' for the treatment of heart failure. The announcement was made by the pharmaceutical company. This decision opens new possibilities for patients suffering from this serious condition. The drug has shown high efficacy in clinical trials. 'We are proud that our country is a pioneer in the implementation of advanced treatment methods,' the company stated.
